| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
RNS News Service
I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.
Willis Towers Watson plc 8.3
RNS
|
RNS Number : 0853D
J.P. Morgan Securities LLC
23 October 2020
Ap19
FORM
8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1.
KEY
INFORMATION
|
Nameofpersondealing
(Note
1)
|
J.P. Morgan Securities LLC
|
|
Companydealtin
|
Willis Towers Watson plc
|
|
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate
(Note
2)
|
US$0.000304635 ordinary shares
|
|
Date
of
dealing
|
22 October 2020
|
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests
and
short
positions
(following
dealing)
in
the
class
of
relevant
security
dealt
in
(Note
3)
|
|
Long
|
Short
|
|
|
Number
|
|
(%)
|
Number
|
|
(%)
|
|
(1)Relevantsecurities
|
2,345,008 1.82
|
2,301,595 1.79
|
|
(2)
Derivatives
(other
than
options)
|
2,309,761 1.79
|
2,240,587 1.74
|
|
(3)Optionsandagreementstopurchase/sell
|
|
|
|
Total
|
4,654,769 3.61
|
4,542,182 3.53
|
| |
|
|
|
|
|
|
Ap20
1.
DEALINGS
(Note
4)
(a) Purchases and sales
|
Purchase/sale
|
Numberofrelevantsecurities
|
Priceperunit(USD)
(Note
5)
|
|
Sale (Borrow Return)
Purchase
Sale
|
175,900
100
100
182
100
100
100
100
100
100
2
3,616
100
100
100
12
100
45
15
3,616
2
100
886
1,027
100
100
1,200
5,716
186
7
100
2,307
300
358
5,746
100
42
43
100
400
100
100
200
2,873
9
400
5
3
100
100
100
100
327
100
17
1
100
100
82
300
100
100
100
100
400
200
100
3,616
100
100
100
3,616
4
1,000
100
1,027
100
100
200
200
1,000
1,200
300
4,744
372
100
100
300
2,873
100
800
100
300
100
2,873
400
100
100
800
100
200
100
600
327
200
2
|
NA
208.1200
208.1300
208.2757
208.3200
208.3300
208.4100
208.5000
208.6100
208.7100
208.7700
208.8100
208.9300
209.1100
209.2600
209.3467
209.3900
209.4093
209.4273
209.4440
209.4600
209.4800
209.4823
209.4975
209.5200
209.5300
209.5498
209.5600
209.5700
209.5757
209.5900
209.6000
209.6100
209.6429
209.6500
209.6700
209.6800
209.6847
209.6900
209.7000
209.7700
209.8100
209.8150
209.8220
209.8267
209.8525
209.8700
209.8867
209.8900
209.9100
209.9248
209.9350
209.9653
210.0000
210.0100
210.0700
208.1200
208.1300
208.2300
208.2600
208.3132
208.3200
208.3300
208.5000
208.5650
208.6100
208.7100
208.8100
208.9300
209.2600
209.3900
209.4440
209.4600
209.4740
209.4800
209.4975
209.5200
209.5300
209.5350
209.5450
209.5460
209.5498
209.5567
209.5600
209.5700
209.5900
209.6100
209.6300
209.6500
209.6900
209.7000
209.7700
209.7933
209.8100
209.8220
209.8525
209.8900
209.9000
209.9075
209.9248
209.9299
209.9350
209.9617
209.9653
210.0000
210.0700
|
(b) Derivatives transactions (other than options transactions)
|
Productname,
e.g.
CFD
|
Natureoftransaction
(Note
6)
|
Numberofrelevantsecurities
(Note
7)
|
Priceperunit
(USD)
(Note
5)
|
|
Equity Swap
|
Short
|
39
964
24
1,200
42
|
209.4877
209.4979
209.4979
209.5498
209.5600
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
|
Productname,
e.g.
call
option
|
Writing,
selling,purchasing,varyingetc.
|
Numberofsecurities towhichtheoptionrelates
(Note
7)
|
Exercise price
|
Type,
e.g.American,Europeanetc.
|
Expiry date
|
Optionmoney paid/receivedperunit
(Note
5)
|
|
|
|
|
|
|
|
|
(ii) Exercising
|
Productname,
e.g.
call
option
|
Numberofsecurities
|
Exercisepriceper unit
(Note
5)
|
|
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
|
Nature
of
transaction
(Note
8)
|
Details
|
Price
per
unit
(if applicable)
(Note 5)
|
|
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on
this
form
or
relating
to
the
voting
rights
or
future
acquisition
or
disposal
of
any
relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached?
(Note
9)
NO
|
Dateofdisclosure
|
23 October 2020
|
|
Contact
name
|
Alwyn Basch
|
|
Telephone
number
|
0207 742 7407
|
|
If
aconnectedEFM,nameofofferee/offerorwithwhichconnected
|
N/A
|
|
If
aconnectedEFM,statenatureofconnection
(Note
10)
|
N/A
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
ISEFXLFLBBLEFBB
|
|
|
|
|
|
